3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide

3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide is an organic chemical compound with CAS number 36734-19-7 and molecular formula C13H13Cl2N3O3. This imidazolidine derivative features a dichlorophenyl group and has a molecular weight of 330.16 g/mol. It is classified as a Category 2 carcinogen and poses significant environmental hazards to aquatic life, requiring careful handling in industrial applications.

3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide has a molecular weight of 330.16 g/mol and contains two chlorine atoms in its dichlorophenyl structure. The compound features an imidazolidine ring system with carbonyl and carboxamide functional groups. Specific physical properties such as melting point, boiling point, and solubility data should be obtained from detailed technical datasheets for precise formulation and handling requirements.

3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide is primarily used in specialized chemical synthesis and research applications. Its imidazolidine structure makes it valuable as an intermediate in pharmaceutical chemistry and organic synthesis. Due to its carcinogenic classification, its use is restricted to professional industrial settings with appropriate safety controls. Specific applications should be confirmed with suppliers to ensure compliance with current regulatory requirements.

3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide requires strict safety precautions due to its Category 2 carcinogen classification. Essential PPE includes chemical-resistant gloves, safety goggles, and respiratory protection in well-ventilated areas or fume hoods. Avoid skin contact, inhalation, and ingestion. Work in designated areas with appropriate engineering controls. All personnel must receive specific training on carcinogenic substance handling before use.

3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide must be stored in a cool, dry, well-ventilated area away from heat and ignition sources. Keep containers tightly sealed and labeled according to CLP requirements with GHS08 and GHS09 pictograms. Store separately from incompatible materials and ensure access is restricted to authorized personnel only. Implement appropriate containment measures to prevent environmental release due to its aquatic toxicity classification.

Immediate action is required upon contact with 3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide due to its carcinogenic properties. For skin contact, remove contaminated clothing and wash thoroughly with soap and water. In case of eye contact, rinse immediately with plenty of water for at least 15 minutes. If inhaled, move to fresh air immediately. Seek medical attention promptly in all cases and inform medical personnel of the substance's carcinogenic classification.

3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide must be disposed of as hazardous waste through licensed waste management companies due to its carcinogenic and aquatic toxicity classifications. Never dispose of via regular waste streams or drain systems. Collect waste in appropriate containers, properly labeled with hazard information. Follow local and national regulations for carcinogenic substance disposal, ensuring complete documentation and traceability throughout the disposal process.

3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide is classified as ADR Class 9 (Miscellaneous Dangerous Substances), Packing Group III for transport purposes. Use appropriate UN-specification packaging and ensure proper labeling with hazard placards. Transport documentation must include proper shipping names and hazard classifications. Drivers require ADR certification for Class 9 materials. Implement measures to prevent environmental release during transport due to aquatic toxicity concerns.

3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide is subject to strict regulatory oversight under REACH and CLP regulations due to its carcinogenic classification. While not currently listed as an SVHC, its Category 2 carcinogen status requires specific risk management measures and safety data sheet provisions. Users must implement appropriate occupational exposure controls and may need authorization for certain uses. Regular monitoring of regulatory updates is essential for compliance.

3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide is available through OYSI, a specialized European distributor of technical chemicals. As a carcinogenic substance, purchase requires verification of legitimate industrial use and appropriate safety infrastructure. OYSI provides comprehensive regulatory support and safety documentation to ensure compliant handling. Contact OYSI's technical team for availability, regulatory guidance, and specific application requirements for this controlled substance.